Literature DB >> 2877192

In-vitro sensitivity of Campylobacter pyloridis to furazolidone.

A Howden, P Boswell, F Tovey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2877192     DOI： 10.1016/s0140-6736(86)92639-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

2.  Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

Authors:  C A McNulty; J C Dent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

3.  Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori.

Authors:  Salman R Hasan; Vahabzadeh Vahid; Pahlvanzadah M Reza; Salman R Roham
Journal:  Saudi J Gastroenterol       Date:  2010 Jan-Mar       Impact factor: 2.485

4.  Furazolidone and serotonin syndrome: is there any association?

Authors:  Petros N Karamanakos
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.